Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases

Ramin Shadman1, Michael H Criqui, Warner P Bundens

  • 1University of California-San Diego, School of Medicine, San Diego, California 92093-0607, USA.

Insights

Subclavian artery stenosis (SS) affects about 2% of the general population and 7% of clinical patients. Risk factors include smoking and high blood pressure, and it

Area of Science:

  • Cardiovascular medicine
  • Vascular disease epidemiology
  • Diagnostic screening

Background:

  • The prevalence of subclavian artery stenosis (SS) in the general population remains largely unknown.
  • Established risk factors and associations with other cardiovascular diseases for SS are not well-defined.

Purpose of the Study:

  • To determine the prevalence of subclavian artery stenosis (SS) in both free-living and clinical populations.
  • To identify risk factors associated with SS.
  • To investigate the relationship between SS and other cardiovascular conditions.

Main Methods:

  • A cross-sectional analysis of 4,223 subjects from two free-living and two clinical cohorts.
  • Subclavian artery stenosis (SS) was defined by an interarm blood pressure difference of >= 15 mm Hg.

Main Results:

  • Prevalence of SS was 1.9% in free-living cohorts and 7.1% in clinical cohorts.
  • SS was significantly associated with past smoking (OR=1.80), current smoking (OR=2.61), and higher systolic blood pressure (OR=1.90 per 20 mm Hg).
  • Higher HDL cholesterol levels showed an inverse association with SS (OR=0.87 per 10 mg/dl).
  • SS was significantly associated with peripheral arterial disease (PAD) (OR=5.11).

Conclusions:

  • Subclavian artery stenosis (SS) is present in approximately 2% of the general population and 7% of clinical patients.
  • SS is linked to smoking history, elevated systolic blood pressure, lower HDL cholesterol, and PAD.
  • Routine bilateral brachial blood pressure measurements are recommended for high-risk individuals to screen for SS and avoid misdiagnosis of hypertension or PAD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...